GPC3 and hepatocellular carcinoma: Serum DCP tests diagnosed HCC with a sensitivity range from 48% to 62% and displayed a specificity between 81% and 98% and achieved an accuracy between 59% and 84%.[7] Other recent studies have suggested a potential role for glypican-3 levels in early HCC detection for HCC screening.